Allspring Global Investments
SLNO

Allspring Global Investments’s Soleno Therapeutics SLNO Stock Holding History

Allspring Global Investments’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-280,984
Closed -$16.9M – 1760
2025
Q3 		$16.9M Buy
280,984
+201,983
+256% +$15M 0.03% 573
2025
Q2 		$6.62M Buy
79,001
+11,652
+17% +$872K 0.01% 821
2025
Q1 		$4.81M Sell
67,349
-60,679
-47% -$2.95M 0.01% 928
2024
Q4 		$5.75M Sell
128,028
-13,396
-9% -$694K 0.01% 907
2024
Q3 		$7.14M Buy
141,424
+7,840
+6% +$375K 0.01% 850
2024
Q2 		$5.45M Buy
133,584
+29,745
+29% +$1.26M 0.01% 930
2024
Q1 		$4.44M Buy
+103,839
New +$4.7M 0.01% 995

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allspring Global Investments's SLNO Position: Q4 2025 in Review

Allspring Global Investments sold out of Soleno Therapeutics (SLNO) in Q4 2025, closing a stake of 280,984 shares — an estimated $16.9M sold.

Allspring Global Investments first reported a position in SLNO in Q1 2024 and held it in 7 quarters. The position peaked at $16.9M in Q3 2025. 248 funds tracked by Wall St. Rank hold SLNO as of Q4 2025.

  • Allspring Global Investments reported no remaining Soleno Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Allspring Global Investments sold 280,984 Soleno Therapeutics shares in Q4 2025, an estimated $16.9M.
  • Allspring Global Investments first reported a position in Soleno Therapeutics in Q1 2024 and held it in 7 quarters.
  • Allspring Global Investments's Soleno Therapeutics position peaked at $16.9M in Q3 2025.
  • 248 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2025.

Based on Allspring Global Investments's 13F filing for Q4 2025, filed 15 Jan 2026.